蛇床子素对绝经后骨质疏松症大鼠骨代谢的调节作用及机制
Regulation effect and mechanism of osthole on bone metabolism in rats with postmenopausal osteoporosis
  
DOI:10.3969/j.issn.1006-7108.2022.02.013
中文关键词:  骨质疏松症  蛇床子素  鼠骨代谢  PI3K/AKT通路
英文关键词:osteoporosis  osthole  bone metabolism in rats  PI3K/AKT pathway
基金项目:河南省卫生厅科研基金(ZY2019DF104)
作者单位
李雷 王峰 刘念 张长城 李刚 宋晓飞 刘瑜 王华磊 赵玉果 杨国志* 南阳市中心医院骨二科河南 南阳 473000 
摘要点击次数: 940
全文下载次数: 0
中文摘要:
      目的 探究蛇床子素对绝经后骨质疏松症(postmenopausal osteoporosis,PMO)模型大鼠骨代谢生化指标及磷脂酰肌醇3-激酶/蛋白激酶B(PI3K/AKT)通路的影响。方法 选取90只雌性大鼠,采用随机数字表法将大鼠分为:健康对照组、模型组、雌二醇组和蛇床子素低、中、高剂量组,每组15只。除健康对照组外各组摘除双侧卵巢制成PMO大鼠模型;雌二醇组采用0.21 mg/kg雌二醇灌胃,低、中、高剂量蛇床子素组分别采用10、20、40 mg/kg的蛇床子素灌胃;完成12周治疗后,检测血清抗酒石酸酸性磷酸酶-5b(TRAP-5b)、骨钙素(OC)和血碱性磷酸酶(ALP),以及尿液钙、磷、肌酐、脱氧吡啶啉(D-Pry)含量水平。分别于治疗8、12周后测定全身骨密度,于治疗12周后检测左侧股骨和腰椎骨密度及右侧股骨和第4腰椎生物力学性能;采用蛋白质印记法检测PI3K/AKT通路相关蛋白相对表达水平。结果 相比健康对照组,模型组TRAP-5b、尿钙/尿肌酐、尿磷/尿肌酐、D-Pry水平均显著升高(P<0.05),OC、ALP、全身骨密度、离体股骨密度、离体椎骨密度、股骨弹性模量和最大载荷、腰椎骨股骨和腰椎骨弹性模量和最大载荷、磷酸化蛋白激酶B/蛋白激酶B(p-AKT/AKT)和磷酸化磷脂酰肌醇3/磷脂酰肌醇3(p-PI3K/PI3K)水平均显著降低(P<0.05)。相比雌二醇组,低、中、高剂量组TRAP-5b、尿钙/尿肌酐、尿磷/尿肌酐、D-Pry水平均显著升高(P<0.05),OC、ALP、全身骨密度、离体股骨密度、离体椎骨密度、股骨和腰椎骨弹性模量和最大载荷、p-AKT/AKT和p-PI3K/PI3K水平均显著降低(P<0.05)。相比模型组,低、中、高剂量组TRAP-5b、尿钙/尿肌酐、尿磷/尿肌酐、D-Pry水平均显著降低,且随着使用剂量增加逐渐降低(P<0.05),OC、ALP、全身骨密度、离体股骨密度、离体椎骨密度、股骨弹性模量和最大载荷、腰椎骨股骨和腰椎骨弹性模量和最大载荷、p-AKT/AKT和p-PI3K/PI3K水平均显著升高,且随着使用剂量的增加逐渐升高(P<0.05)。结论 蛇床子素可呈剂量依赖性地改善PMO大鼠骨代谢,增加骨密度,其作用机制与激活PI3K/AKT信号通路有关。
英文摘要:
      Objective To explore the effects of osthole on biochemical indexes of bone metabolism and phosphoinositide-3 kinase/protein kinase B (PI3K/AKT) pathway in model rats with postmenopausal osteoporosis (PMO). Methods Ninety female rats were enrolled and divided into healthy control group, model group, estradiol group, low-dose, medium-dose, and high-dose osthole groups by random number table method, with 15 cases in each group. Except for healthy control group, bilateral ovaries were removed to prepare PMO rat model. Rats in estradiol group received 0.21 mg/kg of estradiol intragastrically. Rats in low-dose, medium-dose, and high-dose osthole groups received 10, 20, or 40 mg/kg of osthole intragastrically, respectively. After 12-week treatment, the serum levels of anti-tartrate acid phosphatase-5b (TRAP-5b), osteocalcin (OC), and alkaline phosphatase (ALP), urine calcium, phosphorus, creatinine, and deoxypyridinoline (D-Pry) in each group were detected. The systemic bone mineral density (BMD) was measured after 8 and 12 weeks of treatment. BMD of the left femur and lumbar vertebra, and biomechanical properties of the right femur and the fourth lumbar vertebra were detected after 12 weeks of treatment. The relative expression levels of PI3K/AKT pathway-related proteins were detected with Western blotting. Results Compared to those in healthy control group, levels of TRAP-5b, urine calcium/creatinine, urine phosphorus/creatinine, and D-Pry increased significantly (P<0.05), while OC, ALP, systemic BMD, BMD of the isolated femur and vertebrae, elastic modulus and maximum load of the femur, elastic modulus and maximum loads of the lumbar vertebrae, levels of phosphorylated protein kinase B/protein kinase B (p-AKT/AKT) and phosphorylated phosphoinositide-3 kinase/phosphoinositide-3 kinase (p-PI3K/PI3K) decreased significantly in the model group (P<0.05). Compared to those in estradiol group, levels of TRAP-5b, urine calcium/creatinine, urine phosphorus/creatinine, and D-Pry increased significantly (P<0.05), while OC, ALP, systemic BMD, BMD of the isolated femur and vertebrae, elastic modulus and maximum load of the femur and lumbar vertebrae, levels of p-AKT/AKT and p-PI3K/PI3K decreased significantly in low-dose, medium-dose, and high-dose osthole groups (P<0.05). Compared to those in model group, levels of TRAP-5b, urine calcium/creatinine, urine phosphorus/creatinine and D-Pry decreased significantly in low-dose, medium-dose, and high-dose osthole groups (P<0.05), but they gradually decreased with the increase of usage dosage (P<0.05). OC, ALP, systemic BMD, BMD of the isolated femur and vertebrae, elastic modulus and maximum load of the femur, elastic modulus and maximum loads of the lumbar vertebrae, levels of p-AKT/AKT and p-PI3K/PI3K increased significantly (P<0.05), and they gradually increased with the increase of usage dosage (P<0.05). Conclusion Osthole improves bone metabolism and increase BMD with a dose-dependent manner in PMO rats. The action mechanism is related to the activating of PI3K/AKT signaling pathway.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=6BD7BF2FBF911AD9CC9FE9F6A013E002968DB7FEF9DAC7959069F930CDDA753CB4B2C38E80B8C2FCB3B5CBCF9D6E5454D057A77DBF2E3CED3B5F0CA509005DE3A580C51758C05B2DBF5AA1FAAD15FDE2AC31E965D575106D56DE8E2581FE082D7A32AE3F074C672E&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=885CEFEC57DA488F&aid=62C5C4226066866154A9765997F87463&vid=&iid=0B39A22176CE99FB&sid=A1266CF37D675CF1&eid=F8035C8B7D8A4264&fileno=202202013&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="885CEFEC57DA488F"; var my_aid="62C5C4226066866154A9765997F87463";